TRVI vs VMC · $2.32B cap vs P/E 35, rev $7.42B
Trevi Therapeutics Inc (TRVI) versus Vulcan Materials Company (VMC) — a side-by-side from cached financials, not a winner call.
Trevi Therapeutics Inc (TRVI) is a biotechnology company listed on NASDAQ.
Vulcan Materials Company (VMC) is a building materials company listed on NYSE.
TRVI does not have a complete income-statement cache yet.
Latest reported VMC revenue for 2024-12-31 was $7.42B. Net income was $913.1M. Revenue was down 4.7% from 2023-12-31 to 2024-12-31. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
TRVI currently screens at market cap $2.32B. VMC currently screens at market cap $38.25B and trailing P/E 34.9.
Not investment advice. Open the TRVI and VMC stock pages for the full models.
Not investment advice.